Document is current
Any future updates will be listed below
-
Authors
Marbin, Derin https://orcid.org/0000-0003-3409-4220
Piper, Sophie K. https://orcid.org/0000-0002-0147-8992
Lehnerer, Sophie https://orcid.org/0000-0001-9007-027X
Harms, Ulrike https://orcid.org/0000-0003-0533-1434
Meisel, Andreas https://orcid.org/0000-0001-7233-5342
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Exc 257 NeuroCure)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 2 February 2022
Accepted: 10 October 2022
First Online: 11 November 2022
Competing interests
: S.L. has received speaker´s honoraria and honoraria for attendance of advisory boards from Alexion. A.M received speaker´s honoraria from Alexion, Grifols, and Hormosan. He received honoraria from Alexion, UCB, MorphoSys, and Argenx for consulting services and financial research support from Octapharma and Alexion. He is the chairman of the German Myasthenia Gravis Society’s medical advisory board.
